Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials.

Weiting Hu, Rui Song, Rui Cheng, Caihong Liu, Rui Guo, Wei Tang, Jie Zhang, Qian Zhao, Xing Li, Jing Liu

July 2022

Synopsis of Social media discussions

The overall discussions show a mix of cautious support and skepticism, with posts referencing the publication's findings that the evidence for increased thyroid cancer risk is inconclusive, exemplified by phrases like 'no significant risk' and 'pending further evidence.' The tone fluctuates between tentative reassurance and cautious questioning, which indicates moderate engagement and interest without strong emotional investment.

A
Agreement
 Moderate agreement

Many posts agree that the meta-analysis suggests no strong link between GLP-1 use and thyroid cancer, reflecting cautious consensus.

I
Interest
 Neutral level of interest

Overall interest appears neutral; some discussions mention potential risks but do not delve deeply into details.

E
Engagement
 Moderate level of engagement

Posts demonstrate moderate engagement by referencing specific studies, contrasting findings, and questioning data sources.

I
Impact
 Moderate level of impact

The discussions could influence perceptions of GLP-1 safety but generally do not suggest a revolutionary shift in clinical practice.

Social Mentions

YouTube

2 Videos

Twitter

51 Posts

Blogs

2 Articles

News

18 Articles

Metrics

Video Views

1,763

Total Likes

162

Extended Reach

416,014

Social Features

73

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Do GLP-1 Receptor Agonists Increase Thyroid Cancer Risk?

Do GLP-1 Receptor Agonists Increase Thyroid Cancer Risk?

Dr. Eudes Tarallo

November 26, 2023

1,536 views

GLP-1 Receptor Agonists and Thyroid Cancer Risk Assessment

GLP-1 Receptor Agonists and Thyroid Cancer Risk Assessment

This video discusses the potential risks associated with GLP-1 receptor agonists, particularly the connection to thyroid cancer. It examines findings from studies related to the increased risk of thyroid cancer, including medullary thyroid cancer linked to long-term GLP-1 RA treatment.

EndoDirect

November 19, 2022

227 views

  • Nuala Woulfe
    @Nuala_Woulfe (Twitter)

    Research says People taking #semaglutide drugs may also have an increased risk of developing #thyroidcancer . Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomised Controlled Trials - PMC #thyroiddisease #health https://t.co/6xdwmqUaUI
    view full post

    December 29, 2023

  • Medicvs Sine Nimia Vocatione
    @nonono_bueno_no (Twitter)

    @medicoclasto @pochienfadado @chungopailot de ensayos clínicos en 2022 que no demostró aumento de riesgo. Y hay sigue la cosa, pendiente de evolución. Enlaces: https://t.co/Xc55FxbTO4 https://t.co/EZ01ZXbEYK
    view full post

    August 19, 2023

    1

  • C 
    @AsfyXi (Twitter)

    Dock sågs inte samma samband i Hu et al metaanalys från 2022. Hu W, Song R, Cheng R, Liu C, Guo R, Tang W, Zhang J, Zhao Q, Li X, Liu J. Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials. Front Endocrinol Lausanne
    view full post

    July 24, 2023

    2

  • Neil Floch MD
    @NeilFlochMD (Twitter)

    RT @MichaelAlbertMD: In trial data does not describe an association between GLP1 use and thyroid cancer; however, a French national databas…
    view full post

    April 15, 2023

    2

  • Makaveli
    @BMcMullen87 (Twitter)

    RT @MichaelAlbertMD: In trial data does not describe an association between GLP1 use and thyroid cancer; however, a French national databas…
    view full post

    April 13, 2023

    2

  • Michael Albert, MD
    @MichaelAlbertMD (Twitter)

    In trial data does not describe an association between GLP1 use and thyroid cancer; however, a French national database suggests an increase in the hazard for thyroid CA with GLP1 use. Which data are we to believe? [RCTs] https://t.co/JaPsNqYTJV [Observational]
    view full post

    April 12, 2023

    14

    2

  • Rene Sugar
    @renesugar (Twitter)

    Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https://t.co/Aw6mkA54kW
    view full post

    January 17, 2023

    1

  • Amy B. Killen MD
    @KillenMd (Twitter)

    @AbudBakri My understanding is that the thyroid cancer risk has been seen in rodents, but not necessarily humans. But, yes on pancreatitis. https://t.co/ehwBQtbXIx(RR%201.17%2C%2095
    view full post

    January 3, 2023

  • Lourdes Garcia
    @LourdesGDoncel (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 19, 2022

    36

  • LBARendo
    @crazydragonfire (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 19, 2022

    36

  • María Ballesteros
    @mdballesteros (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 19, 2022

    36

  • JoseM Garcia Almeida
    @jgarciaalmeida (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 19, 2022

    36

  • Diego Bellido
    @DiegoBellido2 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 19, 2022

    36

  • Rebeca Reyes
    @rebecareyesgar1 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 19, 2022

    36

  • Lecter
    @AnabelLecter (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 19, 2022

    36

  • b. vanessa deniz
    @VanessitaDeniz (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 19, 2022

    36

  • Nuclear_doc
    @doc_nuclear (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • juan camilo mateus
    @jcmatteus (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Ricardo Pérez Vertti
    @jrvertti (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Diego Schwarzstein
    @diegoschw (Twitter)

    So, MTC increase seems to be a myth... Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https://t.co/7pVNbXOH3v
    view full post

    November 18, 2022

  • Javier Escalada #Yoelijoendocrino
    @fjavesc (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Myriam Beaulieu
    @DraMyriambo10 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Dr Jorge Rico Fontalvo. MD.FISN. FSLANH , PhD
    @jorgericof (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Carlos Palacio
    @CAPE1223 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Dr. Shashank Joshi
    @AskDrShashank (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Kausik Banerjee
    @KBanerjpaeds1 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Elena del Olmo
    @eledelolmo (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • SAEDYN
    @SAEDYN_ (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Miguel Angel Valero
    @mavalero_endo (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Martín López de la Torre
    @elendocrino (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Dr. Hugo Corrales - Endocrinología.
    @hugoendocrino (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Jose De La Flor
    @josedelaflor4 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • The Heart
    @ZHeart11768530 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • m.jesus chinchetru
    @mjchinchetru (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Upe
    @docguada (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Carlos Morillas
    @61Morillas (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Rosa Casañ Fernandez
    @RosaCasan (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Raquel Torres
    @Mafalditapy (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • ENDO-Clínica
    @RAMIROBALDERAS1 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Mubarak
    @Mubarak68735261 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Laura Pérez
    @tatana2007 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • GGMB
    @GabrielMedinaB (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • fausto heredia z.
    @drfherediaz (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Andreea Ciudin
    @AndreeaCiudin1 (Twitter)

    RT @CristobMorales: https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomiz…
    view full post

    November 18, 2022

    36

  • Cristobal Morales
    @CristobMorales (Twitter)

    https://t.co/2lNYVbNKJX Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials (301 trials 94063 participants):
    view full post

    November 18, 2022

    68

    36

  • Alberto Dias Filho
    @albertodiasf (Twitter)

    Frontiers | Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https://t.co/oFgyT6ggzk
    view full post

    November 15, 2022

  • SystematicReviewBot
    @EvidenceRobot (Twitter)

    RT @florencarral: Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https…
    view full post

    October 9, 2022

    2

  • Lecter
    @AnabelLecter (Twitter)

    RT @florencarral: Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https…
    view full post

    October 9, 2022

    2

  • Florentino Carral
    @florencarral (Twitter)

    Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials https://t.co/mAff6AM7Qh
    view full post

    October 9, 2022

    3

    2

  • Armand Domalewski
    @ArmandDoma (Twitter)

    @TaupeAvenger @hyperplanes None of the metastudies I’ve seen suggest a statistically significant risk https://t.co/qRuN6OGVre
    view full post

    September 27, 2022

    2

  • Frontiers - Endocrinology
    @FrontEndocrinol (Twitter)

    New Research: Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials: The association between glucagon-like peptide-1 (GLP-1) receptor agonists and the risk of various… https://t.co/SqbZbSCZrt #Endocrinology #Endo
    view full post

    July 11, 2022

    1

    1

Abstract Synopsis